kabutan

Meiji Holdings Co., Ltd.(2269) Summary

2269
TSE Prime
Meiji Holdings Co., Ltd.
3,739
JPY
+37
(+1.00%)
Apr 28, 3:30 pm JST
23.48
USD
Apr 28, 2:30 am EDT
Result
PTS
outside of trading hours
Summary Chart Historical News Financial Result
PER
27.7
PBR
1.33
Yield
2.81%
Margin Trading Ratio
5.26
Stock Price
Apr 28, 2026
Opening Apr 28, 9:00 am
3,720 JPY 23.34 USD
Previous Close Apr 27
3,702 JPY 23.22 USD
High Apr 28, 2:52 pm
3,741 JPY 23.50 USD
Low Apr 28, 9:04 am
3,710 JPY 23.28 USD
Volume
611,000
Trading Value
2.28B JPY 0.01B USD
VWAP
3733.39 JPY 23.45 USD
Minimum Trading Value
373,900 JPY 2,348 USD
Market Cap
1.06T JPY 6.64B USD
Number of Trades
1,351
Liquidity & Number of Trades
As of Apr 28, 2026
Liquidity
High
1-Year Average
2,656
1-Year High May 9, 2025
11,842
Margin Trading
Date Short Interest Long Margin Positions Ratio
Apr 24, 2026 63,500 95,300 1.50
Apr 17, 2026 79,900 93,700 1.17
Apr 10, 2026 83,200 83,800 1.01
Apr 3, 2026 88,800 94,300 1.06
Mar 27, 2026 606,700 110,100 0.18
Company Profile
Meiji Holdings Co., Ltd. was formed through the integration of Meiji Seika and Meiji Dairies. It is the largest company in the confectionery and dairy industries. The company's pharmaceutical business is experiencing rapid growth, and it is expanding globally.
Sector
Foods
Meiji Holdings Co., Ltd. operates in two business segments: Food and Pharmaceuticals. In the Food segment, the company handles a wide range of products including dairy products, confectioneries, nutritional foods, and animal feed, conducting business through numerous subsidiaries and affiliated companies both domestically and internationally. The Pharmaceutical segment focuses primarily on prescription drugs and veterinary medicines, manufacturing and selling these products through domestic and overseas subsidiaries. As a pure holding company, Meiji Holdings is responsible for formulating group-wide strategies and managing operations. Meiji Co., Ltd. is positioned as the core company in the food business, while Meiji Seika Pharma Co., Ltd. and KM Biologics Co., Ltd. are the core companies in the pharmaceutical business. The company is also focusing on global expansion, with numerous overseas subsidiaries, particularly in Asia.